DGX vs HOTH · P/E 22, rev $5.94B vs rev $1.24B
Quest Diagnostics Incorporated (DGX) versus Hoth Therapeutics Inc (HOTH) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Hoth Therapeutics Inc (HOTH) is a biotechnology company listed on US.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported HOTH revenue for 2024-03-31 was $1.24B. Net income was -$2.1M. HOTH currently screens at market cap $15.5M.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. HOTH currently screens at market cap $15.5M.
Not investment advice. Open the DGX and HOTH stock pages for the full models.
Not investment advice.